Impact of New-onset Insomnia After Coronary Revascularization for Patients With Acute Myocardial Infarction
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Samsung Medical Center
- Enrollment
- 235,342
- Locations
- 1
- Primary Endpoint
- Rates of MACCE
Study Overview
Brief Summary
The present study aimed to evaluate the impact of acute insomnia on long-term clinical outcomes in patients underwent PCI or CABG for AMI using the Korean National Health Insurance Service (NHIS) database, and to identify the factors through which insomnia contributes to prognostic determination in this patient population.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Diagnosis of acute myocardial infarction
- •Undergoing percutaneous coronary intervention or coronary artery bypass surgery
Exclusion Criteria
- •Pre-existing phychiatric disorders
Arms & Interventions
No insomina
patient did not have insomia
Insomnia
patient have insomnia
Intervention: Insomnia medication (Drug)
Insomnia
patient have insomnia
Intervention: No insomnia medication (Other)
Outcomes
Primary Outcomes
Rates of MACCE
Time Frame: up to 10 years
a composite of death, spontaneous MI, repeat revascularization, and ischemic stroke
Secondary Outcomes
- Rates of Ischemic stroke(up to 10 years)
- Rates of Death(up to 10 years)
- Rates of Revascularization(up to 10 years)
- Rates of Spontaneous MI(up to 10 years)
Investigators
Ki Hong Choi
Associate Professor
Samsung Medical Center
